A story I just read about ,”Common thyroid cancer is no longer cancer”.
This has to be good news for many people who will now avoid feeding the cancer industry at great personal cost.
It is has been estimated that 10% to 20% of people who people that have been diagnosed and treated for thyroid cancer were in fact incorrectly diagnosed and treated for a condition that should not be classed as a cancer.
When will these patients be contacted and given an update explaining how this medical mistake happened ?
It is already too late for some patients who took the advice of their doctors and consultants who went on a hunch and decided to treat this thyroid condition with the aggressive treatment designed for cancer without properly looking at the data.
In future they will hopefully be no longer treated with radioiodine or other aggressive approaches.
I wonder how many people had their health destroyed and lives shortened from the side effects from medical treatments for thyroid cancer that was in fact never a cancer.
Many of these people were lightly to have had no symptoms and were screened at their annual health check-up and were so grateful to the doctors who caught and cured thyroid cancer early, while the reality was they never need treatment for cancer in the first place.
These patients may never fully recover and some may already be dead from the side effects of unnecessary operations and treatments ,will the doctors now contact all these patients and their family’s who have been wrongly diagnosed and treated for cancer and at least let them know that they never had cancer in the first place.Even at this late stage people should be told that they were misdiagnosed with cancer and given a review of how this mistake happened and what they now need to do.
Not only does the reclassification eliminate the psychological impact of the diagnosis of ‘cancer,’ it reduces the likelihood of complications of total thyroid removal, and the overall cost of health care.”

Here are the details and links to the story.

A group of 24 doctors from seven countries just reclassified a certain type of thyroid tumor as no longer cancerous, according to a report in JAMA Oncology.

That might not seem like that big of a big deal, but it is. The tumor—formerly called EFVPTC (encapsulated follicular variant of papillary thyroid carcinoma) but now known as NIFTP (noninvasive follicular thyroid neoplasm with papillary-like nuclear features), with no C on the end to designate “carcinoma”—is estimated to make up between 10 and 20 percent of all thyroid cancer diagnoses in Northern America and Europe, according to a press release.

See links http://www.foxnews.com/health/2016/04/15/common-thyroid-cancer-is-no-longer-cancer.html?intcmp=trending

https://www.sciencedaily.com/releases/2016/04/160414113419.htm

Bernie Sanders says medical mistakes are the 3rd cause of death in the US.Good job I live in Ireland that problem is much smaller in Ireland we put the patients on waiting lists.

Here is a video the talks about the common problem of been over diagnosed

The incidence of thyroid cancer has been rising partly due to early detection of tumors that are indolent or non-progressing, despite the presence of certain cellular abnormalities that are traditionally considered cancerous, explained senior investigator Yuri Nikiforov, M.D., Ph.D., professor of pathology and director of Pitt’s Division of Molecular and Genomic Pathology.

“This phenomenon is known as overdiagnosis,” Dr. Nikiforov said. “To my knowledge, this is the first time in the modern era a type of cancer is being reclassified as a non-cancer. I hope that it will set an example for other expert groups to address nomenclature of various cancer types that have indolent behavior to prevent inappropriate and costly treatment.”

“If it’s not a cancer, let’s not call it a cancer,” the president-elect of the American Thyroid Association tells the Times. Similar efforts to reclassify certain lung, prostate, and breast lesions to avoid over-diagnosing cancer are being called for

See more related info at this New York times article
http://www.nytimes.com/2014/11/06/opinion/an-epidemic-of-thyroid-cancer.html?_

The number needed to treat (NNT) is an epidemiological measure used in communicating the effectiveness of a health-care intervention, typically a treatment with medication. The NNT is the average number of patients who need to be treated to prevent one additional bad outcome (e.g. the number of patients that need to be treated for one to benefit compared with a control in a clinical trial). It is defined as the inverse of the absolute risk reduction.

A 2015 study has found out that people who forget calories and sustain a low protein, high carbohydrate diet (LPHC) live as healthy and long as those who limit calories.

Like Us on Facebook

Professor Stephen Simpson, from the University of Sydney, authored the “game-changing” research. Now, there’s finally a feasible alternative to the challenging restricted calorie diet when it comes to living a long and healthy life  and that is by eating high carbohydrates.

University of Sydney Professor said that only a few people can maintain a diet on strict calorie restriction. He expressed that limiting the intake of  calories may lead to negative effects such as “loss of bone mass, libido and fertility”.

Professor Simpson then tried to check how LPHC diet – which he strongly recommends for it is easier to sustain as compared to a Restrcited Calorie diet.

Professor Simpson tested his theory on mice. He placed them on different macronutrient based diets. He experimented his subjects for eight weeks (equal to about two human years).  The genius professor found that those under low protein, high carbohydrate diet and restricted calorie diet lived 30 per cent longer and are healthier.

Surprisingly, despite craving and eating more, the mice under low protein, high carbohydrate diet came out as healthy as those under restricted calorie diet. This was because the opposing diets stimulate the same pathways.

However, Professor Simpson notes that choice of food is still very important when following the more sustainable low protein, high carbohydate diet. For the game-changer Professor, it is never an excuse to eat more sugar as it creates negative consequences.

Research on Mice Suggests We Could Be Better Off Eating More Healthy Carbs and Less Protein

Bad news for the Paleo crowd

While calorie-restriction diets are known to have positive health benefits, a group of researchers in Australia has found that, in mice, a low-protein high-carbohydrate diet produces similar results regardless of caloric intake.

If the study bears out for humans, it could rehabilitate the image of carbohydrates, which has taken a battering in recent years, when the high-protein Atkins and Paleo diets have reigned supreme.

Scientists at the University of Sydney put mice on varying diets in terms of the proportion of carbohydrates, protein and total calories consumed. They found that, in terms of insulin, blood sugar, and cholesterol levels, mice on unrestricted low-protein high-carb diets fared best.

“It still holds true that reducing food intake and body weight improves metabolic health and reduces the risk of diseases like type 2 diabetes, obesity, and fatty liver disease,” said senior author Stephen Simpson of the University of Sydney. “However…it appears that including modest intakes of high-quality protein and plenty of healthy carbohydrates in the diet will be beneficial for health as we age.”

The next step, according to the scientists, will be to learn if specific types of proteins and carbohydrates make a difference in long-term health.

original source http://www.foodworldnews.com/articles/19892/20150529/2015-study-forget-low-calories-live-longer-with-high-carbohydrates.htm

As Dr McDougall has said

Breast cancer is a dominant fear for many women. Fortunately, it’s also largely a preventable disease with the right diet and a healthy lifestyle. Contrary to what most people hope for, early detection by mammography causes more harm than good. Radical surgery, radiation, and chemotherapy are brutal remedies universally prescribed to women with breast cancer, yet they provide little survival benefit. Hormone manipulation is of some value, however the best and most overlooked approach for treating breast cancer is a change in diet and exercise.

See more at this link

Breast Cancer

Test reduces chemo use in breast cancer

[Posted: Fri 20/03/2015 by Deborah Condon www.irishhealth.com]

A test which determines whether chemotherapy will benefit certain women with early-stage breast cancer has proven successful in Ireland.

Around 2,700 new cases of breast cancer are diagnosed in Ireland every year and it is acknowledged that the criteria currently used to decide whether chemotherapy is appropriate may result in overtreatment. In other words, women may receive chemotherapy even if it will not actually treat their disease.

In 2011, Ireland became the first European country to publicly fund the Oncotype DX breast cancer test.

Now, the findings of a major observational study carried out in Ireland have been presented at a major breast cancer conference in Austria. It was carried out to determine both the clinical and financial impact of the test during the first 18 months after it was made publicly available.

The researchers found that among 583 patients with node-negative breast cancer, 345 – that is 59% – underwent a change in their treatment.

Of these 345 patients, 339 patients who would previously have been recommended chemotherapy were changed to hormone therapy alone after the test revealed that they were likely to derive minimal or zero benefit from chemo.

Meanwhile, six patients who would not have been advised to undergo chemotherapy were recommended to get it following the test.

As the test is performed on a small amount of the tissue removed during your original surgery – whether this was a biopsy, lumpectomy or mastectomy – no additional surgery is required to undergo the test.

Aside from the benefits to women who did not have to undergo chemotherapy that was unlikely to help them, the test also saved the HSE around €800,000.

“The HSE was the first public health care system to reimburse this test in Europe. The results from Ireland demonstrate not only the impact of the personalised information Oncotype DX provides on treatment decisions, but also the significant cost savings associated with the use of the test over time,” commented lead researcher, Dr Janice Walshe, a consultant medical oncologist at St Vincent’s University Hospital in Dublin.

She led the research for the All Ireland Co-Operative Oncology Research Group (ICORG) in collaboration with the National Cancer Control Programme (NCCP).

The test was developed by Genomic Health and these findings, along with results from 11 other studies on the test, were presented at the 14th St. Gallen Breast Cancer Conference in Vienna.